Skip to main content

Search Results for

“Telegram刷关注👉【SMMFS.COM】关注粉丝克隆群组,ICK”

May 25, 2020

The results from Osteoporosis Canada’s first national Fracture Liaison Service (FLS) audit demonstrate the positive impact of Canadian FLSs on the lives of fragility fracture patients. The promising results, released […]

May 1, 2019

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

August 2, 2020

  BÜBL™ WINS BRONZE LION This year, Osteoporosis Canada launched a transformative campaign intended to disrupt the osteoporosis landscape, while shining a light on a disease that affects 2 million […]

March 10, 2023

Brookfield Chair in Fracture Prevention Funds New Fracture Liaison Service (FLS) Program in Fredericton, NB

July 15, 2019

Fracture Risk Scale An innovative tool for assessing & managing fracture risk in long-term care Did you know? WHY IS PREVENTING FRACTURES IN LONG-TERM CARE IMPORTANT? The fracture rate in […]

June 15, 2023

With 80% of Canadians suffering from a fragility fracture and not receiving appropriate treatment, Horizon Health Network identified the need for a Fracture Liaison Service (FLS) to reduce care gap individuals with osteoporosis in Fredericton and surrounding areas.

February 1, 2022

The Brookfield Chair in Fracture Prevention St. Clare’s Mercy Hospital 2nd FLS Site in Newfoundland and Labrador New Breakfree Fracture Liaison Service (FLS) established in March 2024 Read more BROOKFIELD […]

January 12, 2024

Latest News IAB Membership Cycle Applications Being Accepted January 12, 2024 Canadian Institutes of Health Research (CIHR) The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for […]

May 31, 2024

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001